the mitoxantrone-containing regimen ( m-bncod ) has equivalent efficacy and reduced toxicity compared to the standard doxorubicin-containing regimen ( m-bacod ) in patients with poor prognosis nhl .
C0013089
doxorubicin
C0083304
m-bacod